Key result
Halothane inhibits cardiac sympathetic ganglia responses to nicotinic receptors via postsynaptic neurons in spinal dogs.
Why the study?
The effects of halothane on cardiac sympathetic ganglia responses to various stimulants were not fully understood.
In a canine model, halothane specifically inhibits nicotinic ganglionic receptors in cardiac sympathetic ganglia via postsynaptic neurons.
Answers are grounded in this paper and cite their sources.
Halothane's ganglionic effects in spinal dogs warrant no clinical change; leaves open postsynaptic mechanisms for human sympathetic research.
The effects of halothane on the responses of cardiac sympathetic ganglia to intra-arterial injection of ganglion stimulants were studied in spinal dogs using heart rate as the index of ganglionic activation. Halothane alone, in concentrations of 1 and 1.5 per cent, did not affect the response to injected acetylcholine. Only after blockade of muscarinic receptors in the ganglion did halothane depress the response to acetylcholine. In addition, halothane markedly inhibited the response to DMPP, a nicotinic receptor stimulant, while leaving unchanged the response to McN-A-343, a muscarinic receptor stimulant. We conclude that halothane specifically inhibits the response to nicotinic ganglionic receptors only, and does so through an effect on the postsynaptic neuron.
No takes yet. Share an insight, caveat, or question.
Alper et al. (1969) studied this question. Halothane was evaluated on Heart rate as the index of ganglionic activation. Halothane specifically inhibited the response of cardiac sympathetic ganglia to nicotinic ganglionic receptors only, acting through an effect on the postsynaptic neuron in spinal dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: